13597EGP
- Active ingredient
- golimumab
- Strength
- 50mg/0.5 ml
- Form
- pen
- Manufacturer
- baxter ag > janssen cilag
- Route
- injection
Uses
Treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and other inflammatory disorders.
Do not use if
Hypersensitivity to golimumab. Severe active infections.
Side effects
Upper respiratory infections, injection-site reactions, headache, and serious infections may occur.
Warnings
Screen for tuberculosis and infections before treatment.
How it works
Golimumab is a monoclonal antibody that inhibits tumor necrosis factor alpha (TNF-α).
Storage
Store refrigerated at 2–8°C and do not freeze.
